Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Abattis Bioceuticals Corp ATTBF

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.


GREY:ATTBF - Post by User

Bullboard Posts
Comment by bmorganstockon Mar 06, 2018 12:46am
108 Views
Post# 27665652

RE:RE:Emc , Vff and Att

RE:RE:Emc , Vff and Att
The Company signed a letter of intent with the Alliance of Beverage Licensees (ABLE BC) to establish an exclusive complementary partnership in ABLE BC's member stores. The letter of intent outlines an exclusive agreement between the Company and ABLE BC to offer expert technical advice regarding the commercialization of cannabis products sold in ABLE BC member stores and locations. 3. The Company has formed a new partnership with Faculty Brewing Co., a Vancouver-based craft brewery, to develop a hemp-infused, cannabinoid-rich, THC (tetrahydrocannabinol)-free craft beer. Pursuant to a research services agreement between the Company and Faculty Brewing, the Company will conduct research and development activities related to the development of a hemp-infused, cannabinoid-rich, THC-free craft beer, or a line of such beers, for Faculty Brewing. 4. The Company acquired Green Tree Therapeutics. As a result of the acquisition, Green Tree becomes a wholly owned subsidiary of the Company and Green Tree's products become available through the Companys wholly owned subsidiary Vergence Naturals Ltd. In connection with the acquisition, the company issued an aggregate of 15 million common shares of the company to the former shareholders of Green Tree. In addition, in consideration for the right to acquire Green Tree, which right was previously held by Winston Resources Inc., the Company issued 15 million shares to Winston. 5. The Company acquired a 49-per-cent stake in CannaNUMUS Blockchain Inc., pursuant to the investment agreement dated Jan. 31, 2018, between the company and CannaNUMUS. Pursuant to Active Health's agreement with CannaNUMUS, CannaNUMUS will invest into Active Health and, in exchange, Active Health will participate as one of CannaNUMUS's blockchain portfolio companies. More specifically, Active Health will use a fixed percentage of its quarterly revenues to buy CannaNUMUS tokens on the open market and subsequently burn them. The effect of the buy and burn will be similar to that when a company repurchases its own stock, and will function as method of providing liquidity to the market for CannaNUMUS tokens. Token burning will also act as a low-friction method of returning value to token holders.
Bullboard Posts